Status™ COVID-19/Flu A&B Rapid Combination Test
Status™ COVID-19/Flu A&B Rapid Combination Test
Status™ COVID-19/Flu A&B Rapid Combination Test
Status™ COVID-19/Flu A&B Rapid Combination Test

Status™ COVID-19/Flu A&B Rapid Combination Test

Regular price $550.00
Sale price $550.00 Regular price
Unit price
Save $0.00
In Stock
  • Free shipping on orders +$250.

  • Save 10% on auto-renew orders.  Learn more
  • Interested in our wholesale program?  Join now
Status™ COVID-19/Flu A&B test is a lateral flow immunoassay intended for the in vitro rapid, simultaneous qualitative detection and differentiation of nucleocapsid antigen from SARS-CoV-2, influenza A and/or influenza B directly from nasopharyngeal swab specimens obtained from individuals, who are suspected of respiratory viral infection consistent with COVID-19 by their healthcare provider, within the first five days of onset of symptoms.

Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. §263a, that meet the requirements to perform moderate, high, or waived complexity tests. This product is authorized for use at the POINT OF CARE (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation.


  • 25 Tests per Box
  • Test type: Lateral flow immunoassay
  • Specimen type: Anterior nasal or nasopharyngeal swab specimens
  • Turnaround time: 15-20 minutes
  • FDA status: Emergency Use Authorization (EUA) Granted
  • CLIA complexity: Waived